Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.AuthorsSharman, Jeffrey P.; Wheler, Jennifer J.; Einhorn, Lawrence; Dowlati, Afshin; Shapiro, Geoffrey I.; Hilton, John; Burke, John M.; Siddiqi, Tanya; Whiting, Nancy; Jalal, Shadia I.PublicationInvestigational New Drugs, 2019, Vol 37, Issue 4, p738ISSN0167-6997Publication typeArticleDOI10.1007/s10637-019-00768-6